Hiv Vaccines
Knowledge and attitudes towards HIV vaccines among Soweto adolescents
... future HIV vaccine trials is contingent on vaccine knowl- edge and to hypothetical trial attributes ...of HIV vaccines was very low, became unwilling to partici- pate with increased ...regarding ...
5
Live attenuated HIV vaccines: Predicting the tradeoff between efficacy and safety
... attenuated HIV vaccines (LAHVs) could be extremely effective in protecting against infection with wild-type strains, but may not be completely safe as the attenuated strain could cause AIDS in some ...
6
Challenges on Induction of Broadly Neutralizing Antibodies for Optimization of HIV Vaccines Development and Vectored Immunoprophylaxis
... non-replicating vaccines (for ...cessful HIV vaccine trial till ...in HIV infections in the vaccinees com- pared to the placebo ...of HIV-1 acquisition, and provide evidence that vac- ...
5
Potential Cost-Effectiveness of Pre-exposure Prophylaxis Combined with HIV Vaccines in the United States
... with HIV vaccines by evaluating the potential cost-effectiveness of implementation that would support the design of clinical trials for assessment of combined product safety and ...standard HIV ...
18
Defining epitope coverage requirements for T cell based HIV vaccines: Theoretical considerations and practical applications
... an HIV vaccine. The ability of HIV-1 to mutate and rapidly evolve to evade host immune pressure is mediated by an error-prone reverse transcriptase, genetic recombination and the host-derived APOBEC editing ...
16
Assembly of Human Immunodeficiency Virus (HIV) Antigens on Bacteriophage T4: a Novel In Vitro Approach To Construct Multicomponent HIV Vaccines
... ber of IFN- ␥ -secreting cells seen with p24 could be due to the presence of more than one CTL epitope in p24. However, only a single CTL epitope, and not overlapping peptides, was tested in the ELISPOT assay. It is ...
11
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
... The RV144 Phase III trial is the only trial in which the clin- ical efficacy, estimated at 31%, of an HIV vaccine has been demonstrated in man [3]. This prime-boost strategy was an attempt to combine an avipox ...
14
Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010
... X4 HIV-1 replication in vitro and that such a co-receptor dependent restriction occurs at a post-entry level ...of HIV-1 infection using expanded primary CD4 + T cells isolated from either healthy children ...
12
Nonneutralizing Functional Antibodies: a New “Old” Paradigm for HIV Vaccines
... (43). Vaccines against feline leukemia virus protect by a mechanism that is not neutralization and may be either nonneutralizing antibody or cytotoxic T lymphocytes ...influenza vaccines that fail to ...
14
Where does public funding for HIV prevention go to? The case of condoms versus microbicides and vaccines
... Within HIV prevention, different approaches can be distinguished, such as prevention by vaccines or microbi- cides, prevention by integrated condom programming, and some recently introduced prevention ...
10
Virally Packaged RNA in Virus-Like Particle Vaccines Enhances Antigenicity and Augments Latency Reversal of HIV-1
... the HIV genome from packaging in our VLPs, we might have inadvertently reduced the latency reversal potential of our VLP ...packaged HIV RNA within viral particles (VP) and compare it to our VLP ...
105
Parents With Doubts About Vaccines: Which Vaccines and Reasons Why
... the vaccines associated with the doubt indicators (sample question: “The last time you had your child vaccinated although you were not sure it was the best thing to do, which vaccinations did your child have?”), ...
10
The development of contraceptive vaccines
... contraceptive vaccines, as in most cases these are aimed at provoking an immune response against a ‘self’ ...contraceptive vaccines would need to stimulate B-cells and helper T-cells in the absence of a ...
26
Therapeutic cancer vaccines
... Preventive vaccination against infectious diseases is considered one of the most successful health measures of all time. Thera- peutic vaccination against established diseases such as persistent infections and cancer has ...
13
Vaccines: the Fourth Century
... Techniques for vaccine manufacture have been constrained by the regulatory acceptability of newer substrates. Until re- cently, the only acceptable substrates have been cells cultured from the organs of animals, human ...
11
Discovery of novel targets for multi epitope vaccines: Screening of HIV 1 genomes using association rule mining
... the HIV proteins are expressed as polypro- teins (such as Gag-Pol) [64], regulation of polypeptide processing in the cell is an important part of the viral life cycle and is often mediated by interactions between ...
12
An Introduction to MCC Vaccines
... Vaccines using outer-membrane vesicle proteins had been de- veloped for use in specific outbreaks in Cuba and New Zealand. They were effective against the outbreak strains but they were not effective against ...
5
Safe Handling of Vaccines
... Measles live and smallpox vaccine 10#{176}C or colder Measles, mumps, and rubella virus 10#{176}C or colder1. vaccine live.[r] ...
7
Ensuring safety of DNA vaccines
... limited. In this review we have mentioned some safety issues to be addressed early in vaccine development. Using bioinformatic tools, safe eukaryotic expression sig- nals can be devised in synthetic DNA sequences. Safety ...
5
Antivirals and vaccines for Enterovirus A71
... EV-A71 vaccines, including inactivating the whole virus, a live attenuated virus, virus-like particles (VLPs), re- combinant subunits, and synthetic peptides, currently, only an inactivated whole virus vaccine for ...
10